CAS Medical Systems has been cleared by the FDA to market its FORE-SIGHT ELITE Absolute Tissue Oximeter, a next-generation device used to provide transitional adolescent and adult patients who weigh at least 40 kilograms with absolute cerebral oxygenation levels. The company plans to release the device during the fourth quarter of this year.

Full Story:
RTT News

Related Summaries